Assembly Biosciences (ASMB) Reports Q3 Loss, Lags Revenue Estimates
Assembly Biosciences: Q3 Earnings Snapshot
UBS Maintains Buy on Assembly Biosciences, Lowers Price Target to $48
Assembly Biosciences to Participate in Upcoming Investor Conferences
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
Assembly Biosciences Doses First Two Patients In Its Phase 2 Clinical Trial Of ABI-6250 To Treat Chronic Hepatitis Delta Virus Infection
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
Assembly Biosciences To Present New Phase 1a Data From Its ABI-6250 Program At The Liver Meeting 2026
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going
Mizuho Maintains Outperform on Assembly Biosciences, Lowers Price Target to $45
Are You Looking for a Top Momentum Pick? Why Assembly Biosciences (ASMB) is a Great Choice
Wall Street Analysts Think Assembly Biosciences (ASMB) Could Surge 40.66%: Read This Before Placing a Bet
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates
Assembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate
Assembly Biosciences: A Gilead-Backed Antiviral Option With More Embedded Leverage Than The Market Appreciates
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.